Cerus Corporation (CU2.DE)
| Previous close | 5.14 |
| Open | 5.14 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 5.14 - 5.14 |
| 52-week range | 4.13 - 6.95 |
| Volume | |
| Avg. volume | 74 |
| Market cap | 942.013M |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
CONCORD, Calif., July 02, 2024--Cerus Corporation (Nasdaq: CERS) today announced the appointment of Dean Gregory to its Board of Directors. Mr. Gregory has a 30+-year career as a leader in the global blood transfusion and cell therapy industry, with broad experience across commercialization, product development, supply chain and manufacturing. For the last decade, Mr. Gregory served as President, Global Commercial Operations, Med Tech for Fresenius Kabi, the role from which he retired earlier th
- Business Wire
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
CONCORD, Calif., June 21, 2024--Cerus Corporation (Nasdaq:CERS) today announced a lunch symposium and selection of abstracts at the 38th International Congress of the International Society of Blood Transfusion (ISBT), taking place in Barcelona, Spain, from June 23 through June 27. Transfusion medicine experts and professionals from around the world attend the ISBT Congress.
- Business Wire
Cerus Corporation Celebrates World Blood Donor Day 2024
CONCORD, Calif., June 14, 2024--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2024.
